Second Trimester Abortion Clinical Trial
Official title:
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion
Verified date | February 2017 |
Source | Rambam Health Care Campus |
Contact | MEIR NIZRI, MD |
Phone | 972-50-2061521 |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion - a Double Blinded Randomized Controlled Trial
Status | Recruiting |
Enrollment | 200 |
Est. completion date | January 2019 |
Est. primary completion date | January 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - healthy - no allergy known to these drugs - second trimester abortion Exclusion Criteria: - hematology diseases - clotting factor deficiency |
Country | Name | City | State |
---|---|---|---|
Israel | Rambam Medical Campus | Haifa |
Lead Sponsor | Collaborator |
---|---|
Rambam Health Care Campus |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduction in Hospital Stay Duration | number of days of hospital stay | Up to 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04063904 -
Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia
|
Phase 4 | |
Completed |
NCT03400358 -
Uterocervical Angle in the Pregnancy Termination of Multiparous Women
|
N/A | |
Recruiting |
NCT04501809 -
Second Trimester Pregnancy Termination in Women With Previous Caesarean Sections
|
N/A | |
Enrolling by invitation |
NCT06078501 -
MisOpRostol Effect on Second Trimester Abortion Blood Loss
|
Phase 3 | |
Completed |
NCT04181541 -
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
|
N/A | |
Completed |
NCT06164067 -
The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination
|
||
Completed |
NCT02033083 -
Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation
|
N/A | |
Recruiting |
NCT06123026 -
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
|
Phase 4 | |
Terminated |
NCT03714880 -
Cervical Preparation With Mifepristone Prior to Osmotic Dilators
|
Phase 2 | |
Completed |
NCT03407521 -
Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion
|
Phase 4 |